BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28533162)

  • 1. Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis.
    Rao YJ; Hui C; Chundury A; Schwarz JK; DeWees T; Powell MA; Mutch DG; Grigsby PW
    Brachytherapy; 2017; 16(4):831-840. PubMed ID: 28533162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
    Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
    Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy vs. external beam radiotherapy for choroidal melanoma: Survival and patterns-of-care analyses.
    Abrams MJ; Gagne NL; Melhus CS; Mignano JE
    Brachytherapy; 2016; 15(2):216-23. PubMed ID: 26846381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
    Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.
    Jackson MW; Amini A; Jones BL; Kavanagh B; Maroni P; Frank SJ; Mahmood U; Kudchadker RJ; Pugh TJ
    Brachytherapy; 2017; 16(4):790-796. PubMed ID: 28442277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
    Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
    Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
    Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
    Stokes WA; Jones BL; Schefter TE; Fisher CM
    Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
    Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study.
    Yang K; Ma Y; Chen G; Zeng S; Guo T; Yang Z
    Radiat Oncol; 2022 Oct; 17(1):174. PubMed ID: 36307810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of external beam radiation therapy and radioactive implants in the management of nonmetastatic oral squamous cell cancer: an analysis of the surveillance epidemiology and end results database.
    Agaku IT; Akinyele AO
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jan; 115(1):38-45. PubMed ID: 23021918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
    Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
    Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma.
    Boothe D; Hopkins Z; Frandsen J; Lloyd S
    J Gastrointest Oncol; 2016 Aug; 7(4):580-7. PubMed ID: 27563448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
    Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
    Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.